LT2909192T - Su metilenu sujungti rop-gama-t chinolinilo moduliatoriai - Google Patents
Su metilenu sujungti rop-gama-t chinolinilo moduliatoriaiInfo
- Publication number
- LT2909192T LT2909192T LTEP13786564.8T LT13786564T LT2909192T LT 2909192 T LT2909192 T LT 2909192T LT 13786564 T LT13786564 T LT 13786564T LT 2909192 T LT2909192 T LT 2909192T
- Authority
- LT
- Lithuania
- Prior art keywords
- ror
- gamma
- methylene linked
- quinolinyl modulators
- linked quinolinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261714419P | 2012-10-16 | 2012-10-16 | |
US201261725528P | 2012-11-13 | 2012-11-13 | |
US201361782257P | 2013-03-14 | 2013-03-14 | |
PCT/US2013/065013 WO2014062658A1 (en) | 2012-10-16 | 2013-10-15 | Methylene linked quinolinyl modulators of ror-gamma-t |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2909192T true LT2909192T (lt) | 2017-07-10 |
Family
ID=49546611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP13786564.8T LT2909192T (lt) | 2012-10-16 | 2013-10-15 | Su metilenu sujungti rop-gama-t chinolinilo moduliatoriai |
Country Status (38)
Country | Link |
---|---|
US (1) | US9290476B2 (lt) |
EP (1) | EP2909192B1 (lt) |
JP (1) | JP6466335B2 (lt) |
KR (1) | KR20150070347A (lt) |
CN (1) | CN105209453B (lt) |
AR (1) | AR093017A1 (lt) |
AU (1) | AU2013331496B2 (lt) |
BR (1) | BR112015008308A2 (lt) |
CA (1) | CA2888210C (lt) |
CL (1) | CL2015000945A1 (lt) |
CR (1) | CR20150193A (lt) |
CY (1) | CY1119234T1 (lt) |
DK (1) | DK2909192T3 (lt) |
EA (1) | EA026415B1 (lt) |
EC (1) | ECSP15015022A (lt) |
ES (1) | ES2632269T3 (lt) |
GT (1) | GT201500093A (lt) |
HK (1) | HK1213248A1 (lt) |
HR (1) | HRP20171082T1 (lt) |
HU (1) | HUE035335T2 (lt) |
IL (1) | IL237866B (lt) |
LT (1) | LT2909192T (lt) |
ME (1) | ME02794B (lt) |
MX (1) | MX358508B (lt) |
MY (1) | MY189505A (lt) |
NI (1) | NI201500053A (lt) |
NZ (1) | NZ706775A (lt) |
PE (1) | PE20150778A1 (lt) |
PH (1) | PH12015500817A1 (lt) |
PL (1) | PL2909192T3 (lt) |
PT (1) | PT2909192T (lt) |
RS (1) | RS56283B1 (lt) |
SG (1) | SG11201502369XA (lt) |
SI (1) | SI2909192T1 (lt) |
TW (1) | TWI606045B (lt) |
UY (1) | UY35084A (lt) |
WO (1) | WO2014062658A1 (lt) |
ZA (1) | ZA201503418B (lt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2014008856A (es) * | 2012-02-13 | 2014-12-15 | Hoffmann La Roche | Derivados de imidazolilcetona como inhibidores de aldosterona sintasa. |
TWI627174B (zh) | 2013-03-14 | 2018-06-21 | 比利時商健生藥品公司 | P2x7調控劑 |
EP2970283B1 (en) | 2013-03-14 | 2020-11-11 | Boehringer Ingelheim International GmbH | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
WO2014152537A1 (en) | 2013-03-14 | 2014-09-25 | Janssen Pharmaceutica Nv | P2x7 modulators |
TWI644671B (zh) | 2013-03-14 | 2018-12-21 | 比利時商健生藥品公司 | P2x7調節劑 |
EP2970271B1 (en) | 2013-03-14 | 2017-11-08 | Janssen Pharmaceutica NV | P2x7 modulators |
EP3044219A1 (en) * | 2013-09-09 | 2016-07-20 | Bristol-Myers Squibb Company | Rorgamma modulators |
US9284308B2 (en) * | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
EP3560920A1 (en) * | 2013-10-15 | 2019-10-30 | Janssen Pharmaceutica NV | Secondary alcohol quinolinyl modulators of ror gamma t |
CN105829294B (zh) * | 2013-10-15 | 2018-11-09 | 詹森药业有限公司 | ROR-γ-T的与亚甲基连接的喹啉基调节剂 |
JP6423423B2 (ja) | 2013-10-15 | 2018-11-14 | ヤンセン ファーマシューティカ エヌ.ベー. | Rorγtのアルキル結合キノリニルモジュレーター |
US10555941B2 (en) * | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
AU2014334616A1 (en) | 2013-10-15 | 2016-04-28 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORyt |
SG11201609722UA (en) * | 2014-05-28 | 2016-12-29 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
US9988374B2 (en) | 2014-08-11 | 2018-06-05 | Angion Biomedica Corp. | Cytochrome P450 inhibitors and uses thereof |
JP6592510B2 (ja) | 2014-09-12 | 2019-10-16 | ヤンセン ファーマシューティカ エヌ.ベー. | P2x7調節因子 |
AP2017009733A0 (en) | 2014-09-12 | 2017-02-28 | Boehringer Ingelheim Int | Spirocyclic inhibitors of cathepsin c |
AU2015374231B2 (en) | 2014-12-31 | 2020-07-23 | Angion Biomedica Corp. | Methods and agents for treating disease |
TW202028198A (zh) | 2018-09-28 | 2020-08-01 | 比利時商健生藥品公司 | 單醯基丙三醇脂酶調節劑 |
US20200102311A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Pharmaceutica Nv | Monoacylglycerol Lipase Modulators |
US10947253B2 (en) | 2019-08-05 | 2021-03-16 | Ankh Life Sciences Limited | Fused polycyclic dimers |
MX2022003819A (es) | 2019-09-30 | 2022-05-11 | Janssen Pharmaceutica Nv | Ligandos de pet de mgl radiomarcados. |
CA3156332A1 (en) * | 2019-10-31 | 2021-05-06 | Jiangsu Hengrui Medicine Co., Ltd. | Acid addition salt of ror.gamma. regulator |
WO2021191359A1 (en) | 2020-03-26 | 2021-09-30 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators |
EP4143179A1 (en) | 2020-04-30 | 2023-03-08 | Idorsia Pharmaceuticals Ltd | Azetidin-3-ylmethanol derivatives as ccr6 receptor modulators |
CN112939974B (zh) * | 2021-03-11 | 2023-10-20 | 中山大学 | 一种氮杂苯并薁衍生物的制备方法 |
WO2023057548A1 (en) | 2021-10-07 | 2023-04-13 | Idorsia Pharmaceuticals Ltd | Ccr6 receptor modulators |
AR127450A1 (es) | 2021-10-26 | 2024-01-24 | Idorsia Pharmaceuticals Ltd | Moduladores del receptor ccr6 |
CA3236396A1 (en) | 2021-10-28 | 2023-05-04 | Oliver Allemann | Ccr6 receptor modulators |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472859A (en) | 1966-11-01 | 1969-10-14 | Sterling Drug Inc | 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters |
JPS4826772U (lt) | 1971-08-02 | 1973-03-31 | ||
ATE27451T1 (de) | 1981-03-24 | 1987-06-15 | Ciba Geigy Ag | Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung. |
US4656283A (en) | 1982-05-25 | 1987-04-07 | American Cyanamid Company | Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid |
US4910327A (en) | 1982-05-25 | 1990-03-20 | American Cyanamid Company | Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof |
US4710507A (en) | 1983-12-22 | 1987-12-01 | Pfizer Inc. | Quinolone inotropic agents |
FR2634483B2 (fr) | 1987-12-29 | 1994-03-04 | Esteve Labor Dr | Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments |
CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
EP0584222B1 (en) | 1991-05-10 | 1997-10-08 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
US5478832A (en) | 1992-05-08 | 1995-12-26 | The Green Cross Corporation | Quinoline compounds |
JPH0826772A (ja) | 1994-07-22 | 1996-01-30 | Sony Corp | 融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法 |
ES2136782T3 (es) | 1994-10-27 | 1999-12-01 | Asahi Glass Co Ltd | Procedimiento para producir compuestos de acido quinolin-2-il-benzoico. |
GB9523267D0 (en) | 1995-11-14 | 1996-01-17 | Sandoz Ltd | Organic compounds |
IL123568A (en) | 1995-12-08 | 2001-08-08 | Janssen Pharmaceutica Nv | History (Imidazole - 5Il) Methyl-2-quinolinone inhibitors of Prenzyl transferase, their preparation, pharmaceutical preparations containing them and their preparation and drugs containing them |
WO1997044339A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
CN1231215C (zh) * | 1997-06-02 | 2005-12-14 | 詹森药业有限公司 | (咪唑-5-基)甲基-2-喹啉酮衍生物用作平滑肌细胞增殖抑制剂 |
HUP0101999A3 (en) | 1997-12-22 | 2003-06-30 | Upjohn Co | 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them |
FR2776388B1 (fr) | 1998-03-20 | 2006-04-28 | Lipha | Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose |
US6399629B1 (en) | 1998-06-01 | 2002-06-04 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
EA003877B1 (ru) | 1998-07-06 | 2003-10-30 | Янссен Фармацевтика Н.В. | Ингибиторы фарнезилпротеинтрансферазы, обладающие in vivo радиосенсибилизирующими свойствами |
UA64797C2 (uk) * | 1998-07-06 | 2004-03-15 | Янссен Фармацевтика Н.В. | Інгібітори фарнезил білок трансферази як засіб для лікування артропатії |
JP2000169451A (ja) | 1998-09-30 | 2000-06-20 | Kyorin Pharmaceut Co Ltd | 6,7―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法 |
PT1140935E (pt) | 1998-12-23 | 2003-10-31 | Janssen Pharmaceutica Nv | Derivados da quinolina 1,2-ciclizada |
US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
US6248736B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
ID29584A (id) | 1999-02-11 | 2001-09-06 | Pfizer Prod Inc | Turunan-turunan kuinolin-2-on tersubstitusi heteroaril yang bermanfaat sebagai zat-zat anti kanker |
EP1106612B1 (en) | 1999-11-30 | 2004-02-11 | Pfizer Products Inc. | Quinoline derivatives useful for inhibiting farnesyl protein transferase |
WO2001056552A2 (en) | 2000-02-04 | 2001-08-09 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitors for treating breast cancer |
JP2003523381A (ja) | 2000-02-24 | 2003-08-05 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 投与レジメン |
US20030078281A1 (en) | 2000-02-29 | 2003-04-24 | Rybak Mary Ellen Margaret | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents |
EP1261343A2 (en) | 2000-02-29 | 2002-12-04 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives |
CA2397425A1 (en) | 2000-02-29 | 2001-09-07 | Ivan David Horak | Farnesyl protein transferase inhibitor combinations with taxane compounds |
WO2001064197A2 (en) | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
US20030027808A1 (en) | 2000-02-29 | 2003-02-06 | Palmer Peter Albert | Farnesyl protein transferase inhibitor combinations with platinum compounds |
AU2001239275A1 (en) | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
EP1261374A2 (en) | 2000-02-29 | 2002-12-04 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
US20030022918A1 (en) | 2000-02-29 | 2003-01-30 | Horak Ivan David | Farnesyl protein transferase inhibitor combinations with an her2 antibody |
CA2397240A1 (en) | 2000-02-29 | 2001-09-07 | Peter Albert Palmer | Farnesyl protein transferase inhibitor combinations with camptothecin compounds |
CA2397694A1 (en) | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica Inc. | Farnesyl protein transferase inhibitor combinations |
AU2001242434A1 (en) | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
US6844357B2 (en) | 2000-05-01 | 2005-01-18 | Pfizer Inc. | Substituted quinolin-2-one derivatives useful as antiproliferative agents |
US6525049B2 (en) | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
US6624159B2 (en) | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
WO2002004462A1 (en) | 2000-07-12 | 2002-01-17 | Pharmacia & Upjohn Company | Oxazinoquinolones useful for the treatment of viral infections |
WO2002024682A1 (en) | 2000-09-25 | 2002-03-28 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
EP1322644A1 (en) | 2000-09-25 | 2003-07-02 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
ES2313991T3 (es) | 2000-09-25 | 2009-03-16 | Janssen Pharmaceutica Nv | Derivados de 6-heterociclilmetil-quinolina y quinazolina que inhiben la farnesil transferasa. |
EE05195B1 (et) | 2000-10-02 | 2009-08-17 | Janssen Pharmaceutica N.V. | Kinoliini ja kinolinooni derivaadid glutamaatretseptori antagonistidena, nende saamine ja kasutamine ravimite valmistamiseks ning neid sisaldav farmatseutiline kompositsioon |
EP1339407B1 (en) | 2000-11-28 | 2006-04-19 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
US7129356B2 (en) | 2000-12-27 | 2006-10-31 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
US20040110769A1 (en) | 2001-02-15 | 2004-06-10 | End David William | Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
US6544990B2 (en) | 2001-03-01 | 2003-04-08 | Pharmacia & Upjohn Company | Substituted quinolinecarboxamides as antiviral agents |
EP1390033A1 (en) | 2001-04-25 | 2004-02-25 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitors for treating cachexia |
US6706699B2 (en) | 2001-06-21 | 2004-03-16 | Ariad Pharmaceuticals, Inc. | Quinolines and uses thereof |
US20030207877A1 (en) | 2001-12-20 | 2003-11-06 | Strohbach Joseph Walter | Pyridoquinoxaline antivirals |
EP1456208A1 (en) | 2001-12-20 | 2004-09-15 | PHARMACIA & UPJOHN COMPANY | Pyridoquinoxaline antivirals |
KR101061561B1 (ko) | 2002-03-29 | 2011-09-02 | 얀센 파마슈티카 엔.브이. | 대사자극성 글루타메이트 수용체 리간드로서 방사능표지된 퀴놀린 및 퀴놀리논 유도체 및 그의 용도 |
AU2003257822A1 (en) | 2002-08-13 | 2004-04-30 | Shionogi And Co., Ltd. | Heterocyclic compound having hiv integrase inhibitory activity |
AU2003262947A1 (en) | 2002-08-30 | 2004-03-19 | Pharmacia And Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
GB0222516D0 (en) | 2002-09-27 | 2002-11-06 | Karobio Ab | Novel compounds |
JP4920410B2 (ja) | 2003-07-14 | 2012-04-18 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 代謝モジュレーターとしての縮合アリールおよびヘテロアリール誘導体ならびに代謝に関連する障害の予防および治療 |
WO2005054201A1 (en) | 2003-11-20 | 2005-06-16 | Janssen Pharmaceutica N.V. | 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
JP4806353B2 (ja) | 2003-12-05 | 2011-11-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ポリ(adp−リボース)ポリメラーゼインヒビターとしての6−置換2−キノリノンおよび2−キノキサリノン |
WO2005058843A1 (en) | 2003-12-10 | 2005-06-30 | Janssen Pharmaceutica N.V. | Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
BRPI0417543A (pt) | 2003-12-12 | 2007-03-27 | Wyeth Corp | quinolinas úteis no tratamento de doença cardiovascular |
SG166019A1 (en) | 2004-01-23 | 2010-11-29 | Janssen Pharmaceutica Nv | Quinoline derivatives and use thereof as mycobacterial inhibitors |
CN1910154B (zh) | 2004-01-29 | 2011-08-17 | 詹森药业有限公司 | 用作分枝杆菌抑制剂的喹啉衍生物 |
JP2005225250A (ja) | 2004-02-10 | 2005-08-25 | Murakami Corp | 車載用監視装置 |
EA012416B1 (ru) | 2004-06-30 | 2009-10-30 | Янссен Фармацевтика Н.В. | Производные замещенного 2-алкилхиназолинона как ингибиторы parp |
ES2407813T3 (es) | 2004-08-04 | 2013-06-14 | Meiji Seika Pharma Co., Ltd. | Derivados de quinolina e insecticida que contienen los mismos como constituyente activo |
KR100686531B1 (ko) | 2004-08-31 | 2007-02-23 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법 |
ME01509B (me) | 2004-11-05 | 2014-04-20 | Janssen Pharmaceutica Nv | Terapeutska upotreba inhibitora farneziltransferaze i postupci praćenja njihove efikasnosti |
JO2855B1 (en) | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2952B1 (en) | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
WO2007088978A1 (ja) | 2006-02-03 | 2007-08-09 | Meiji Seika Kaisha, Ltd. | 新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤 |
US8389739B1 (en) | 2006-10-05 | 2013-03-05 | Orphagen Pharmaceuticals | Modulators of retinoid-related orphan receptor gamma |
EA016527B1 (ru) | 2006-10-23 | 2012-05-30 | ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК. | Триазолопиридазиновые модуляторы протеинкиназ |
JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
AR065093A1 (es) | 2007-02-05 | 2009-05-13 | Merck Frosst Canada Ltd | Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos |
UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
WO2008112525A2 (en) | 2007-03-09 | 2008-09-18 | Link Medicine Corporation | Treatment of lysosomal storage diseases |
WO2008144767A1 (en) | 2007-05-21 | 2008-11-27 | Sgx Pharmaceuticals, Inc. | Heterocyclic kinase modulators |
CN101143845B (zh) | 2007-10-15 | 2010-08-25 | 中国药科大学 | 取代喹啉甲酰胍衍生物、其制备方法及其医药用途 |
BRPI0906927A2 (pt) | 2008-01-18 | 2015-07-21 | Allergan Inc | Compostos de substituída-aril-(imidazol)-metil)-fenila como moduladores seletivos de subtipo de receptores alfa 2b e/ou alfa 2c adrenérgicos |
JP2011511056A (ja) | 2008-02-05 | 2011-04-07 | ファイザー・インク | Cns障害および代謝障害治療のためのピリジニルアミド |
AU2009246601A1 (en) | 2008-05-13 | 2009-11-19 | Allergan, Inc. | Quinolynylmethylimidizoles as therapeutic agents |
WO2010068296A1 (en) | 2008-12-11 | 2010-06-17 | Stiefel Laboratories, Inc. | Piperazine carboxamidines as antimicrobial agents |
WO2010127208A1 (en) | 2009-04-30 | 2010-11-04 | Forest Laboratories Holdings Limited | Inhibitors of acetyl-coa carboxylase |
CN101899011B (zh) | 2009-05-26 | 2013-01-16 | 北京大学 | 氨基二硫代甲酸酯类化合物、其制备方法和应用 |
AR077004A1 (es) | 2009-06-09 | 2011-07-27 | Hoffmann La Roche | Compuestos heterociclicos antivirales |
MX2011013510A (es) | 2009-06-25 | 2012-03-07 | Amgen Inc | Compuestos heterociclicos y sus usos. |
JP5775871B2 (ja) | 2009-08-20 | 2015-09-09 | ノバルティス アーゲー | ヘテロ環式オキシム化合物 |
EP2368886A1 (en) | 2010-03-01 | 2011-09-28 | Phenex Pharmaceuticals AG | Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease |
US9101600B2 (en) | 2010-03-11 | 2015-08-11 | New York University | Compounds as RORγt modulators and uses thereof |
CA2796077A1 (en) | 2010-04-15 | 2011-10-20 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
JP6063870B2 (ja) * | 2010-11-08 | 2017-01-18 | ライセラ・コーポレイション | RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療 |
EP2678052B1 (en) | 2011-02-24 | 2018-09-26 | Emory University | Jab1 blocking compositions for ossification and methods related thereto |
TWI532728B (zh) | 2011-04-28 | 2016-05-11 | 日本煙草產業股份有限公司 | 醯胺化合物及其醫藥用途 |
US9586928B2 (en) | 2011-05-16 | 2017-03-07 | The Scripps Research Institute | Modulators of the nuclear hormone receptor ROR |
GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
WO2013064231A1 (en) | 2011-10-31 | 2013-05-10 | Phenex Pharmaceuticals Ag | SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3) |
WO2013079223A1 (en) | 2011-12-02 | 2013-06-06 | Phenex Pharmaceuticals Ag | Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
-
2013
- 2013-10-15 SI SI201330702T patent/SI2909192T1/sl unknown
- 2013-10-15 ES ES13786564.8T patent/ES2632269T3/es active Active
- 2013-10-15 PL PL13786564T patent/PL2909192T3/pl unknown
- 2013-10-15 PE PE2015000491A patent/PE20150778A1/es active IP Right Grant
- 2013-10-15 CA CA2888210A patent/CA2888210C/en active Active
- 2013-10-15 HU HUE13786564A patent/HUE035335T2/en unknown
- 2013-10-15 JP JP2015537769A patent/JP6466335B2/ja not_active Expired - Fee Related
- 2013-10-15 DK DK13786564.8T patent/DK2909192T3/en active
- 2013-10-15 AR ARP130103735A patent/AR093017A1/es unknown
- 2013-10-15 UY UY0001035084A patent/UY35084A/es unknown
- 2013-10-15 MY MYPI2015701186A patent/MY189505A/en unknown
- 2013-10-15 MX MX2015004783A patent/MX358508B/es active IP Right Grant
- 2013-10-15 TW TW102137062A patent/TWI606045B/zh not_active IP Right Cessation
- 2013-10-15 CN CN201380065903.1A patent/CN105209453B/zh not_active Expired - Fee Related
- 2013-10-15 EP EP13786564.8A patent/EP2909192B1/en active Active
- 2013-10-15 NZ NZ706775A patent/NZ706775A/en not_active IP Right Cessation
- 2013-10-15 LT LTEP13786564.8T patent/LT2909192T/lt unknown
- 2013-10-15 KR KR1020157012838A patent/KR20150070347A/ko active IP Right Grant
- 2013-10-15 PT PT137865648T patent/PT2909192T/pt unknown
- 2013-10-15 EA EA201590736A patent/EA026415B1/ru unknown
- 2013-10-15 AU AU2013331496A patent/AU2013331496B2/en not_active Ceased
- 2013-10-15 US US14/053,653 patent/US9290476B2/en not_active Expired - Fee Related
- 2013-10-15 ME MEP-2017-151A patent/ME02794B/me unknown
- 2013-10-15 RS RS20170741A patent/RS56283B1/sr unknown
- 2013-10-15 WO PCT/US2013/065013 patent/WO2014062658A1/en active Application Filing
- 2013-10-15 SG SG11201502369XA patent/SG11201502369XA/en unknown
- 2013-10-15 BR BR112015008308A patent/BR112015008308A2/pt not_active Application Discontinuation
-
2015
- 2015-03-22 IL IL237866A patent/IL237866B/en active IP Right Grant
- 2015-04-13 CR CR20150193A patent/CR20150193A/es unknown
- 2015-04-14 PH PH12015500817A patent/PH12015500817A1/en unknown
- 2015-04-15 EC ECIEPI201515022A patent/ECSP15015022A/es unknown
- 2015-04-15 CL CL2015000945A patent/CL2015000945A1/es unknown
- 2015-04-15 NI NI201500053A patent/NI201500053A/es unknown
- 2015-04-15 GT GT201500093A patent/GT201500093A/es unknown
- 2015-05-15 ZA ZA2015/03418A patent/ZA201503418B/en unknown
-
2016
- 2016-02-01 HK HK16101098.1A patent/HK1213248A1/zh not_active IP Right Cessation
-
2017
- 2017-07-14 HR HRP20171082TT patent/HRP20171082T1/hr unknown
- 2017-07-25 CY CY20171100793T patent/CY1119234T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1213248A1 (zh) | -γ- 的亞甲基連接的喹啉基調節劑 | |
HK1211316A1 (en) | Mirna modulators of thermogenesis mirna | |
IL238122A0 (en) | Phenyl-linked quinolinyls are ror-gamma-t modulators | |
HK1201199A1 (en) | Methods of using fgf19 modulators fgf19 | |
LT3461895T (lt) | Ube3a-ats raiškos moduliavimas | |
ZA201406082B (en) | Use of ccr3-inhibitors | |
IL237868A0 (en) | Heteroaryl-linked quinolinyls are roryt modulators | |
IL266446A (en) | Androgen synthesis modulators | |
IL236312A0 (en) | Preparation of 18f-flucyclobin | |
EP2881113A4 (en) | NEW APPLICATION OF POGOSTONE | |
IL245020A0 (en) | Methylene-linked quinolinyls are ror–gamma–t modulators | |
TWI561801B (en) | Testing of optical devices | |
PL2888228T3 (pl) | Inhibitory oddziaływania CD40-TRAF6 | |
EP2892529A4 (en) | USES OF (-) - PERHEXILINE | |
GB201215942D0 (en) | Method of treatent | |
TWM433525U (en) | Structure of calorifier | |
TWM433502U (en) | Improved structure of lamp cap |